|
 |
|
| Home > In Vitro Diagnostics |
| |
| |
|
| |
 In Vitro Diagnostics Market Research Reports |
French Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
This report provides:Five-year sales forecasts for the French Molecular Diagnostics market, including: - Infectious Diseases- Cancer- Forensic Testing- Genetic Diseases- Paternity Testing/HLA Typing, and other applications.
|
 |
|
$750.00 |
| |
|
|
|
German Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
This report provides:Five-year sales forecasts for the German Molecular Diagnostics market, including: - Infectious Diseases- Cancer- Forensic Testing- Genetic Diseases- Paternity Testing/HLA Typing, and other applications.
|
|
|
$750.00 |
| |
|
|
|
Italian Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
This report provides:Five-year sales forecasts for the Italian Molecular Diagnostics market, including: - Infectious Diseases- Cancer- Forensic Testing- Genetic Diseases- Paternity Testing/HLA Typing, and other applications.
|
|
|
$750.00 |
| |
|
|
|
Japanese Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
This report provides:Five-year sales forecasts for the Japanese Molecular Diagnostics market, including: - Infectious Diseases- Cancer- Forensic Testing- Genetic Diseases- Paternity Testing/HLA Typing, and other applications.
|
|
|
$750.00 |
| |
|
|
|
Spanish Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
This report provides:Five-year sales forecasts for the Spanish Molecular Diagnostics market, including: - Infectious Diseases - Cancer - Forensic Testing - Genetic Diseases - Paternity Testing/HLA Typing, and other applications.
|
|
|
$750.00 |
| |
|
|
|
The UK Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
This report provides:Five-year sales forecasts for the UK Molecular Diagnostics market, including: - Infectious Diseases - Cancer - Forensic Testing - Genetic Diseases - Paternity Testing/HLA Typing, and other applications.
|
|
|
$750.00 |
| |
|
|
|
The US Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
This report provides:Five-year sales forecasts for the US Molecular Diagnostics market, including: - Infectious Diseases - Cancer - Forensic Testing - Genetic Diseases - Paternity Testing/HLA Typing, and other applications.
|
|
|
$750.00 |
| |
|
|
|
France Tumor Markers Testing Market: Sales Forecasts By Market Segment and Supplier Shares by Test
This report provides an overview of the French cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$750.00 |
| |
|
|
|
Germany Tumor Markers Testing Market: Sales Forecasts By Market Segment and Supplier Shares by Test
This report provides an overview of the German cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$750.00 |
| |
|
|
|
Japan Tumor Markers Testing Market: Sales Forecasts By Market Segment and Supplier Shares by Test
This report provides an overview of the Japanese cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$750.00 |
| |
|
|
|
Spain Tumor Markers Testing Market: Sales Forecasts By Market Segment and Supplier Shares
This report provides an overview of the Spanish cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
|
|
|
$750.00 |
| |
|
|
|
Carbamazepine: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketReserach.com provides analysis of Carbamazepine testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Amikacin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Amikacin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Albumin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Albumin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Alkaline Phosphatase: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Alkaline Phosphatase testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
ALT/SGPT: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of ALT/GPT testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Ammonia: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Ammonia testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Amylase: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Amylase testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
|